CN103110100A - Korean medical healthcare food composition as well as preparation method and application thereof - Google Patents
Korean medical healthcare food composition as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN103110100A CN103110100A CN2013100465080A CN201310046508A CN103110100A CN 103110100 A CN103110100 A CN 103110100A CN 2013100465080 A CN2013100465080 A CN 2013100465080A CN 201310046508 A CN201310046508 A CN 201310046508A CN 103110100 A CN103110100 A CN 103110100A
- Authority
- CN
- China
- Prior art keywords
- root
- composition
- preparation
- chinese
- health food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 235000013305 food Nutrition 0.000 title abstract description 18
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 31
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 31
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 30
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 30
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 30
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 30
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 29
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000008187 granular material Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000012141 concentrate Substances 0.000 claims abstract description 5
- 239000006072 paste Substances 0.000 claims abstract description 5
- 239000003826 tablet Substances 0.000 claims abstract description 5
- 239000007910 chewable tablet Substances 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000007901 soft capsule Substances 0.000 claims abstract description 3
- 240000002045 Guettarda speciosa Species 0.000 claims abstract 7
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 2
- 235000013402 health food Nutrition 0.000 claims description 36
- 240000006079 Schisandra chinensis Species 0.000 claims description 32
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 31
- 235000013399 edible fruits Nutrition 0.000 claims description 31
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 27
- 241000245665 Taraxacum Species 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 13
- 235000004879 dioscorea Nutrition 0.000 claims description 10
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 10
- 235000013312 flour Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000011950 custard Nutrition 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 235000012970 cakes Nutrition 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims 6
- 239000003814 drug Substances 0.000 abstract description 39
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 37
- 244000248557 Ophiopogon japonicus Species 0.000 abstract description 27
- 210000004072 lung Anatomy 0.000 abstract description 25
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 14
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 235000014347 soups Nutrition 0.000 abstract description 8
- 210000001124 body fluid Anatomy 0.000 abstract description 6
- 239000010839 body fluid Substances 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 241000906579 Actaea cimicifuga Species 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003517 fume Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 68
- 238000012360 testing method Methods 0.000 description 53
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 239000008103 glucose Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 239000000047 product Substances 0.000 description 26
- 239000013558 reference substance Substances 0.000 description 24
- 241000125175 Angelica Species 0.000 description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 22
- 239000000523 sample Substances 0.000 description 22
- 230000006870 function Effects 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 239000013642 negative control Substances 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 9
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 244000281702 Dioscorea villosa Species 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000005352 clarification Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 2
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000905376 Actaea dahurica Species 0.000 description 1
- 241000906577 Actaea heracleifolia Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000008556 Huangqin-Tang Substances 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- QURCVMIEKCOAJU-HWKANZROSA-N Isoferulic acid Natural products COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 241001058321 Taraxacum sinicum Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000013103 analytical ultracentrifugation Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- JXQGGZBUGUHLEJ-UHFFFAOYSA-N butyl acetate formic acid hydrate Chemical compound O.OC=O.CCCCOC(C)=O JXQGGZBUGUHLEJ-UHFFFAOYSA-N 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- VWOQSIOHOUWUAL-UHFFFAOYSA-N chloroform methane Chemical compound [H]C[H].ClC(Cl)Cl.ClC(Cl)Cl VWOQSIOHOUWUAL-UHFFFAOYSA-N 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical group O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- FYSHYFPJBONYCQ-UHFFFAOYSA-N schisanhenol Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2O FYSHYFPJBONYCQ-UHFFFAOYSA-N 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Korean medical healthcare food composition. The Korean medical healthcare food composition is a preparation prepared from the raw materials including kudzuvine root, dandelion, Chinese yam, shizandra, ophiopogon root, platycodon root, angelica root and cimicifuga foetida; and the dosage forms of the composition comprise powder, granules, tablets, chewable tablets, capsules, soft capsules, oral liquid, pastes, concentrates, ointments, soups, cakes and drinks. The composition has a healthcare function of assistant blood sugar reduction. The invention also provides a preparation method and an application of the composition. The composition has a formula which is screened out according to Chinese Korean theories of medicine on the basis of a Korean medicine clinical empirical prescription for preventing and treating diabetes, and meets requirements for healthcare foods. The composition can be used for treating the symptoms of diabetes and the like caused by phlogistic fire which fumes entrails, generates heat and dryness, causes qi flaming and secretion dryness, and makes one cannot restrain oneself by drinking due to accidental joy and anger, excessive consumption of energy, declined blood after illness, improper diet, deficiency of Yin and the like, and the aim of assistant blood sugar reduction is achieved by tonifying and astringing the lung, moistening dryness and resolving phlegm, promoting the production of body fluid to relieve exterior syndromes and clearing heat, so that a new choice is provided for the development of healthcare foods. The preparations prepared from the Korean medical healthcare food composition are experimentally proved to have the healthcare function of assistant blood sugar reduction and do not have toxic or side effect.
Description
Technical field
The present invention relates to a kind of health-care food composition, specifically refer to have auxiliary hyperglycemic function towards medical insurance health food composition and method of making the same and purposes, belong to health food development, production, use field.
Background technology
The present invention is take China towards theory of medicine as the basis, according to the regulation of " health food registration management way ", develops a kind of health-care food composition with auxiliary hyperglycemic function and preparation method thereof.Its composite formula Main Basis is used for the proved recipe of control " lunar people " diabetes in the medical science, and concrete composition derives from medicine food dual purpose plant commonly used.
Diabetes (Diabetesmellitus, DM) are to continue hyperglycaemia as one group of endocrine metabolism disease of feature.Wherein common with diabetes B, account for more than 90% of diabetes patient's sum.Diabetes B has become one of three the highest large NCDs of world's M ﹠ M, and the incidence of disease is ascendant trend year by year, especially rises the most obvious with developing countries such as China, the Indian subcontinent, Africa.Therefore, further strengthen the research to diabetes, the control of actively developing diabetes and complication thereof is the urgent task that present the world of medicine faces.The traditional Chinese medicine prevention diabetes have long history, have accumulated the experience of a large amount of preciousnesses.The anti-diabetic activity composition in Chinese medicine source particularly has gentle lasting, the characteristics such as side effect is little, can use for a long time of therapeutic action, and its mechanism of action is often many target spots, manifold effect, multi-functional comprehensive function, and the irreplaceable comprehensive advantage of Western medicine is arranged.The traditional Chinese medical science is Stages, diagnosis and treatment and specially side's treatment to the treatment major programme of DM, has obtained certain curative effect in clinical individualized treatment, but the drug development that is fit to the group feature treatment achieving no breakthrough property progress still.
China is on the basis of the intrinsic culture base of Korean nationality and east medicine towards medical science, absorbs the theory of traditional Chinese medicine and pharmacy, and in conjunction with this nationality experience of preventing and curing diseases, progressively formation and development is got up.Be take " my god, people, generation, " Overall View as theoretical direction towards medical science, take the structure of " four-quadrant of the four-dimension " as principal mode, resemble (physique, disease) and the dialectical diagnoses and treatment that combines to distinguish.Be Syndrome Differentiation of Constitution towards one of most important theories of medical science, the crowd is divided into four kinds of sun people, lunar people, few positive people, few cloudy people by physique, wherein lunar people accounts for more than 50%, and number is maximum.Lunar people easily causes suffering from diabetes because of its physique characteristic, finds towards doctor's clinical investigation, and DM patient is lunar people more than 70%.To the DM patient treatment time, towards medical science according to patient's physique characteristic in conjunction with the disease medication, prescription used is relatively stable and evident in efficacy, is particularly suitable for being developed as new drug or the health food of group feature prevention and treatment.Present clinical use represents prescription towards doctor " lunar people ", has accumulated certain experience as treatment DM such as " the civil and military soup of a thousand pieces of gold ".
This product formula is is suitably added and subtracted with reference to towards doctor's clinical proved recipe, is comprised of medicine food dual purpose plants such as the root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletops.
In formula, the root of kudzu vine, Chinese yam, balloonflower root, the root of Dahurain angelica, Dandelion are in the article that are food and medicine, and the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, rattletop are the article that can be used for health food.In formula, whole flavour of a drug form and meet health food to the requirement of raw material sources.
The root of kudzu vine is the dry root of legume pueraria lobata Pueraria lobata (willd.) ohwi, and spring and autumn is excavated, and removes impurity, dries.The property of medicine is sweet, hot, and is cool.Return spleen, stomach warp.Be the tcm clinical practice medicine that expels pathogenic wind from the body surface commonly used, the pharmacological actions such as hypoglycemic, antitumor, analgesic, expansion of cerebral vascular, step-down, reducing heart rate, reduction MCO, diastole smooth muscle are arranged.Think that towards the doctor root of kudzu vine is lunar people's medicine.Function is for dispersing expelling pathogenic factors from muscles and skin, and is clearing heat and detoxicating, promotes the production of body fluid to quench thirst.Be mainly used in lunar people Yang Ming, positive malicious flushing, throat disease, fever with aversion to cold, order pain nasal cavity dryness, body heat stomachache also is used for lunar people's typhoid fever from sharp person, and the more fever with less chills card is vomited and diarrhoea, cholera, difficult urination, five drench, headache, face heat waits card.Root of kudzu vine expelling pathogenic factors from muscles and skin soup in " east doctor's Longevity and Life Preservation " with clearing heat and detoxicating, is dispersed expelling pathogenic factors from muscles and skin, controls lunar people's Yangming disease; More chills and less fever soup, clearing heat and detoxicating to disperse wind-heat, control lunar people's typhoid fever, more fever with less chills card.
Dandelion is feverfew dandelion Taraxacum mongolicum Hand.-Mazz., alkali ground dandelion Taraxacum sinicum Kitag. or the dry herb that belongs to several plants together.Spend spring to autumn when just opening and excavate, remove impurity, clean, dry.The property of medicine is bitter, sweet, and is cold.Return liver, stomach warp.Be tcm clinical practice heat-clearing and detoxifying drug commonly used, resisting pathogenic microbes is arranged, protect the liver, the pharmacological actions such as cholagogic, anti-gastric-ulcer, enhancing immunologic function, diuresis.Think that towards the doctor dandelion is lunar people's medicine.Function is clearing heat and detoxicating, and dampness removing is treating stranguria, the carbuncle that disappears dissipating bind.Be mainly used in carbuncle sore, throat disease and liver kidney syndrome of dampness-heat." east doctor's Longevity and Life Preservation " more fever with less chills Tonga dandelion treatment liver kidney humidifier.
Chinese yam is the dry rhizome of Dioscoreaceae herbaceos perennial Chinese yam Dioscorea opposita Thunb..Excavate autumn, cleans, and after scraping off the processing such as tertia, dries or air-dry, running through section and using.The property of medicine is flat, and is sweet.Return spleen, lung, kidney channel.The main active of Chinese yam is Chinese yam polysaccharide.Have the protection of hypoglycemic, liver, anti-ageing, antitumor, regulate or strengthen immunologic function, oxidation resistant pharmacological action.Chinese yam polysaccharide can reduce blood sugar and lipids contents, improves liver glycogen and myocardium glycogen content, illustrates that Chinese yam has hypoglycemic activity, and can promote the blood sugar utilization.Think that towards the doctor Chinese yam is lunar people's medicine.The merit that function is kept in having for strong lung is invigorated the spleen and benefited qi.Be mainly used in having loose bowels, the consumptive disease dream is let out, and also is used for lunar people and spits blood, the diseases such as hemorrhagic vertigo.The Chinese yam soup that clears away heart-fire in " east doctor four-quadrant newly organized ", to invigorate the spleen and benefit qi, clearing away the heart fire and tranquillizing is controlled the consumptive disease dream and is let out, and abdomen is not had loose bowels bitterly, aphasia from apoplexy disease.Lung first medicine soup in mountain in " east doctor's Longevity and Life Preservation " is controlled the diseases such as haematemesis, bleeding from five sense organs or subcutaneous tissue, hemorrhagic vertigo.．
The fruit of Chinese magnoliavine is the ripening fruits of magnoliaceae schisandra Schisandra chinesis (Turcz.) Bail or schisandra chinensis Schisandra sphenanthera Rehd.et Wils..Gather during fruit maturation autumn, dries.The property of medicine is sour, sweet, warm.Return lung, the heart, kidney channel.Has convergence astringent or styptic treatment for spontaneous sweating, nourishing generate fluid, the effect of kidney calming.Be used for the treatment of nourishing generate fluid, the nourshing kidney of astringing the lung, antidiarrheal, puckery essence, calm the nerves, can control that chronic cough void is breathed heavily, the diseases such as the few dry in Tianjin, seminal emission are rushed down for a long time, forgetful insomnia.The traditional Chinese medical science thinks that the fruit of Chinese magnoliavine protects the liver, hypoglycemic, hypotensive, stimulating central nervous system system and respiratory system, kobadrin, enhancing cellular immunity, anti-oxidant, anti-ageing, resistance to compression, vasodilatory pharmacological action.Think towards the doctor: the fruit of Chinese magnoliavine is lunar people's medication, and the effect of strong lung tonifying lung is arranged.Be mainly used in lunar people's cough, thirsty hidrosis, palpitaition, insomnia, dreaminess.This product has the merit of strong lung, often joins the tuber of dwarf lilyturf, balloonflower root etc." east doctor four-quadrant newly organized " " Chinese ephedra Jinsui River soup " has the merit of the arrest sweating of promoting the production of body fluid, and often joins the tuber of dwarf lilyturf, with the arrest sweating that promotes the production of body fluid, clearing away summerheat, and treatment palpitaition, insomnia, dreaminess.Modern study thinks that the fruit of Chinese magnoliavine contains abundant organic acid, vitamin, flavonoids, phytosterol and the lignan (as schizandrin, deoxyschizandrin or fruit of Chinese magnoliavine fat element) of potent reactivation is arranged, it is also one of minority medicinal material that has concurrently essence, gas, god's three large helps, the strong liver of the beneficial gas of energy, the efficient of promoting the cells exclude refuse, supply more oxygen, construction and uses energy, raising memory and property endurance.
The tuber of dwarf lilyturf is liliaceous plant Ophiopogon tuber of dwarf lilyturf japonicus(Thumb.) the piece root of Ker-Gawl..Usually excavate summer, clean and remove fibrous root, dry.The property of medicine is sweet, little hardship, is slightly cold.Return stomach, lung, the heart channel of Hang-Shaoyin.Be tcm clinical practice drugs for nourishing yin commonly used, the pharmacological action of hypoglycemic, anti-ageing, antitumor, radioresistance, anti-arrhythmia, enhancing cellular immunity is arranged.The traditional Chinese medical science thinks that the tuber of dwarf lilyturf has nourishing Yin and promoting production of body fluid, the effect that moistening lung clears away heart-fire.Can be used for dryness of the lung dry cough; Lung carbuncle; Deficiency of Yin labor is coughed; Tianjin wound is thirsty; Quench one's thirst; Vexed insomnia; Have sore throat; The dry constipation of intestines; Blood-head is told the treatment of nosebleed.Think that towards the doctor tuber of dwarf lilyturf is lunar people's medicine.The moistening lung of function tonifying lung, clearing heat and moistening dryness.Be mainly used in lunar people in conditioner and heatstroke after being ill, polydipsia, summer fever is sick.Record in " eastern doctor's Longevity and Life Preservation ": " the first soup of conditioning lung " with tonifying lung and lung, fire-draining and dryness moisturizing is used for conditioner greatly after being ill.
Balloonflower root is Campanulaceae Platycodon grandiflorum(Jacq.) root of A.DC..Spring and autumn is excavated, and removes the seedling stem, cleans, and scrapes off cork, dries.The property of medicine is bitter, and suffering is flat.Return lung channel.Have a surname's lung, eliminate the phlegm, relieve sore throat, the effect of apocenosis.That balloonflower root has is hypoglycemic, protect the liver, antibechic, relaxing smooth muscle, eliminate the phlegm, oxidation resistant pharmacological action.Think that towards the doctor balloonflower root is lunar people's medication, have strong lung and outer power of pushing up is arranged.Record in " east doctor's Longevity and Life Preservation ": " balloonflower root Huangqin-Tang ", with dispersing superficial exopathogens, throat is controlled lunar people's throat disease.
The root of Dahurain angelica is the dry root of samphire root of Dahurain angelica Angelica dahurica (Fisch. ex Hoffm.) Benth. et Hook. f. or anti-root of Dahurain angelica Angelica dahurica (Fisch. ex Hoffm.) Benth. et Hook. f. Var. formosana (Boiss.) Shan et Yuan..Excavate when between Xia Qiu, leaf is yellow, remove fibrous root, dry.The property of medicine is hot, temperature.Return stomach, large intestine, lung channel.The main active of the root of Dahurain angelica is furocoumarin.The pharmacological actions such as analgesia, analgesic, anti-inflammatory, resisting pathogenic microbes, spasmolysis, stimulating central nervous system system are arranged.Think that towards the doctor root of Dahurain angelica is lunar people's medicine.Function for induce sweat, wind-expelling pain-stopping.Be mainly used in lunar people's headache, positive malicious flushing, sore-throat, the cards such as nasosinusitis.
Rattletop is the dry rhizome of ranunculaceae plant C.heracleifolia Cimicifuga heracleifolia Kom., Cimicifuga Dahurica Cimicifuga dahurica (Turcz.) Maxim. or rattletop Cimicifuga foetida L..Excavate autumn, removes silt, shines when doing to fibrous root, burns or remove fibrous root, dries.The property of medicine is hot, little sweet, is slightly cold.Return lung, spleen, stomach, large intestine channel.Step-down arranged, suppress cardiac muscle, the pharmacological actions such as reducing heart rate, antibiotic, calm, anticonvulsion, analgesic cooling.Think that towards the doctor rattletop is lunar people's medicine.Function is for dispersing wind-heat, detoxifcation promoting eruption, elevate a turnable ladder yang-energy.
Having no at present take China towards theory of medicine is the health food listing of compound basis, and retrieval Chinese patent and bibliographic data base have no the health food patent similar to present composition formula and study report, present composition design theory and thinking innovation.Have the health food of auxiliary hyperglycemic function take the present invention as foundational development, the market demand has a extensive future.
Summary of the invention
Technical scheme of the present invention provide a kind of take China towards medical science health theory as foundation, have the health-care food composition of auxiliary hyperglycemic function, it be by meet " health food registration management way " regulation natural material and supplementary product compatibility be prepared from.The present invention also provides preparation method and the purposes of this compound health-care food compositions.
The invention provides a kind of have auxiliary hyperglycemic towards medical insurance health food composition, it is the preparation of being made by the raw material of following weight proportioning:
Root of kudzu vine 4-60 part, dandelion 2-30 part, Chinese yam 2-30 part, fruit of Chinese magnoliavine 1-15 part, tuber of dwarf lilyturf 1-15 part, balloonflower root 1-15 part, root of Dahurain angelica 1-15 part, rattletop 1-15 part.
Further preferred, it is the preparation of being made by the raw material of following weight proportioning:
20 parts of the roots of kudzu vine, 10 parts of dandelions, 10 parts of Chinese yams, 5 parts, the fruit of Chinese magnoliavine, 5 parts of the tuber of dwarf lilyturfs, 5 parts of balloonflower roots, 5 parts of the roots of Dahurain angelica, 5 parts of rattletops.
Health-care food composition of the present invention, it is to be active component by the root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop medicinal material or medicinal substances extract, adds the preparation that the acceptable auxiliary material of health food or complementary composition are prepared from.
Wherein, described preparation formulation comprises: pill, powder, granule, tablet, chewable tablets, capsule, soft capsule, oral liquid, paste, concentrate, paste, custard, cake, beverage.
The present invention also provides the preparation method of this health-care food composition, and it comprises the steps:
(1) take the raw material of weight proportion: root of kudzu vine 4-60 part, dandelion 2-30 part, Chinese yam 2-30 part, fruit of Chinese magnoliavine 1-15 part, tuber of dwarf lilyturf 1-15 part, balloonflower root 1-15 part, root of Dahurain angelica 1-15 part, rattletop 1-15 part;
(2) get that the root of kudzu vine, dandelion, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop add water or organic solvent extracts, get extract 1, get Chinese yam, be ground into fine powder, cross 100 mesh sieves, yam flour, or get that the root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop add water or organic solvent extracts, get extract 2;
(3) get extract 1 and yam flour mixing, add acceptable auxiliary material or complementary composition in health food, make respectively preparation by corresponding shaping technique, or get extract 2 and add acceptable auxiliary material or complementary composition in health food, make respectively preparation by corresponding shaping technique.
Health-care food composition of the present invention is that foundation is Chinese towards theory of medicine, take towards the clinical proved recipe be used to preventing and treating diabetes of doctor as the basis, filters out the formula that meets the healthy food material requirement, and concrete composition derives from medicine food dual purpose plant commonly used.Careless for the happiness anger that " lunar people " physique occurs, take up one's energy excessively, blood declines after being ill, eating and drinking without temperance, the reasons such as the element body deficiency of Yin cause the upper smoked internal organs of scorching fire, Heat of Formation is dry, dries up in gas vehement Tianjin, can not draw drink from prohibiting, become the symptom such as quench one's thirst, by tonifying lung astringe the lung, moistening dryness and resolving phlegm, promote the production of body fluid induce sweat, the merit of heat-clearing, reach the purpose of auxiliary hyperglycemic, for the exploitation health food provides a kind of new selection.
The specific embodiment
Below in conjunction with experimental example and embodiment, the present invention is described in more detail.
Embodiment 1
Health food of the present invention is to be made by the raw material of following weight: the root of kudzu vine 600 g, dandelion 300 g, Chinese yam 300 g, the fruit of Chinese magnoliavine 150 g, the tuber of dwarf lilyturf 150 g, balloonflower root 150 g, the root of Dahurain angelica 150 g, rattletop 150 g.
And health food of the present invention is by preparing as the next stage:
The root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, the rattletop boiling of (1) getting above-mentioned weight are extracted 2 times, filter, merging filtrate, get extract, get refined liquid after extract process adsorption clarification or supercentrifugation are refining, get medicinal extract after the refined liquid reduced pressure concentration, standby;
(2) get proper auxiliary materials and mix with above-mentioned medicinal extract, drying is pulverized, and crosses 100 mesh sieves, and take 50 % ethanol as wetting agent softwood processed, extrusion is crossed 14 mesh sieves and granulated, and drying is crossed the 16 whole grains of mesh sieve, gets granule.
Embodiment 2
Health food of the present invention is to be made by the raw material of following weight: the root of kudzu vine 300 g, dandelion 200 g, Chinese yam 200 g, the fruit of Chinese magnoliavine 150 g, the tuber of dwarf lilyturf 150 g, balloonflower root 150 g, the root of Dahurain angelica 150 g, rattletop 100 g.
And health food of the present invention is by preparing as the next stage:
(1) get the root of kudzu vine, the dandelion of above-mentioned weight, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop boiling are extracted 2 times, filter, merging filtrate gets extract, gets refined liquid after extract process adsorption clarification or supercentrifugation are refining, get medicinal extract after the refined liquid reduced pressure concentration, standby;
(2) get Chinese yam and be processed into powder, cross 100 mesh sieves, get yam flour, standby;
(3) get yam flour 200 g and mix with above-mentioned medicinal extract, drying is pulverized, and crosses 100 mesh sieves, and take 50 % ethanol as wetting agent softwood processed, extrusion is crossed 14 mesh sieves and granulated, and drying is crossed the 16 whole grains of mesh sieve, gets dried particle, and dried particle tablet press machine compressing tablet namely gets chewable tablets.
Embodiment 3
Health food of the present invention is to be made by the raw material of following weight: the root of kudzu vine 600 g, dandelion 300 g, Chinese yam 250 g, the fruit of Chinese magnoliavine 200 g, the tuber of dwarf lilyturf 200 g, balloonflower root 200 g, the root of Dahurain angelica 150 g, rattletop 150 g.
And health food of the present invention is by preparing as the next stage:
(1) get the root of kudzu vine, the dandelion of above-mentioned weight, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop boiling are extracted 2 times, filter, merging filtrate gets extract, gets refined liquid after extract process adsorption clarification or supercentrifugation are refining, the refined liquid reduced pressure concentration gets concentrate, and is standby;
(2) get Chinese yam and be processed into powder, cross 100 mesh sieves, get yam flour, standby;
(3) get 100g agar and put into 20 times of amount concentrates, be heated to dissolving after immersion 10h, add honey element, natural antiseptic agent, stir evenly, be heated to 80 ℃, get yam flour 250g and add, stir, pressure sterilizing lets cool to 80 ℃ of injection moldings, namely gets the custard agent.
Embodiment 4
Health food of the present invention is to be made by the raw material of following weight: the root of kudzu vine 500 g, dandelion 300 g, Chinese yam 300 g, the fruit of Chinese magnoliavine 250 g, the tuber of dwarf lilyturf 250 g, balloonflower root 200 g, the root of Dahurain angelica 150 g, rattletop 150 g.
And health food of the present invention is by preparing as the next stage:
(1) get the root of kudzu vine, the dandelion of above-mentioned weight, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop boiling are extracted 2 times, filter, and merging filtrate gets extract, get refined liquid after extract process adsorption clarification or supercentrifugation are refining, and be standby;
(2) get above-mentioned refined liquid and add appropriate flavouring, stabilizing agent, mixing filters, and adds appropriate pure water to be diluted to ormal weight, mixing, and can, sterilization namely gets beverage.
The discriminating of experimental example 1 granule of the present invention
(1) thin layer of the root of kudzu vine is differentiated and is got this product powder 6 g, adds methyl alcohol 10 mL, places 2 h, filters, and filtrate evaporate to dryness, residue add methyl alcohol 0.5 mL makes dissolving, as need testing solution.Get root of kudzu vine control medicinal material 1 g, be made in the same way of control medicinal material solution.Get preparation 1 g that lacks the root of kudzu vine, be made in the same way of negative control solution.Get the Puerarin reference substance, add methyl alcohol and make the solution that every 1 mL contains 1mg, product solution in contrast.According to the thin-layered chromatography test, draw above-mentioned four kinds of solution, put respectively on same silica gel g thin-layer plate, take chloroform-methanol-water (7.5:2:0.25) as solvent, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect.Result with reference substance chromatogram and control medicinal material chromatogram relevant position on, the spot of the aobvious same color of test sample chromatogram, negative control solution is without corresponding spot.
(2) thin layer of dandelion is differentiated and is got this product powder 10g, adds methyl alcohol 50ml, adds hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue add water 10ml makes dissolving, filters, filtrate is extracted 2 times with the ethyl acetate jolting, each 10ml, combined ethyl acetate liquid, evaporate to dryness, residue adds methyl alcohol 1ml makes dissolving, as need testing solution.Separately get the caffeic acid reference substance, add methyl alcohol and make the solution that every 1ml contains 0.5mg, in contrast product solution.According to the thin-layered chromatography test, draw each 6 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, take the upper solution of butyl acetate-formic acid-water (7:2.5:2.5) as solvent, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect.In the test sample chromatogram, with reference substance chromatogram corresponding position on, the fluorescence spot of aobvious same color.
(3) thin layer of Chinese yam is differentiated and to be got this product powder 10 g, and 30 mL that add methylene chloride add hot reflux 2 h, filters, and filtrate evaporate to dryness, residue 1 mL that adds methylene chloride makes dissolving, as need testing solution.Get Chinese yam control medicinal material 5 g, be made in the same way of control medicinal material solution.Get preparation 5 g that lack Chinese yam, be made in the same way of negative control solution.Test according to thin-layered chromatography (10 editions appendix VI B of Chinese Pharmacopoeia), draw above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take ethyl acetate-methyl alcohol-strong ammonia solution (9:1:0.5) as solvent, launch, take out, dry, spray is heated to the spot colour developing with 10% phosphomolybdic acid ethanol solution at 105 ℃.Result with control medicinal material chromatogram relevant position on, the spot of the aobvious same color of test sample chromatogram, the negative control product are without corresponding spot.
(4) fruit of Chinese magnoliavine thin layer is differentiated and is got this product powder 10 g, adds chloroform 30 mL, adds hot reflux 30 min, filters, and filtrate evaporate to dryness, residue add chloroform 1 mL makes dissolving, as need testing solution.Get fruit of Chinese magnoliavine control medicinal material 1 g, be made in the same way of control medicinal material solution.Get preparation 10 g that lack the fruit of Chinese magnoliavine, be made in the same way of negative control solution.Get the schizandrin A reference substance, add chloroform and make the solution that every 1 mL contains 1mg, product solution in contrast.Test according to thin-layered chromatography (10 editions appendix VI B of Chinese Pharmacopoeia), draw above-mentioned four kinds of solution, put respectively on same silica GF254 lamellae, take the upper solution of benzinum (30-60 ℃)-ethyl acetate-formic acid (15:5:1) as solvent, launch, take out, dry, put under ultraviolet lamp (254nm) and inspect.Result with reference substance chromatogram and control medicinal material chromatogram relevant position on, the spot of the aobvious same color of test sample chromatogram, the negative control product are without corresponding spot.
(5) tuber of dwarf lilyturf, this product powder 10 g were got in the thin layer discriminating, added chloroform-methane (7:3) mixed solution 30 mL, soaked 3 h, and ultrasonic processing 30 min let cool, and filtered, and filtrate evaporate to dryness, residue add chloroform 0.5 mL makes dissolving, as need testing solution.Get the control medicinal material 2 g tuber of dwarf lilyturf, be made in the same way of control medicinal material solution.Get preparation 5 g that lack the tuber of dwarf lilyturf, be made in the same way of negative control solution.According to the thin-layered chromatography test, draw above-mentioned three kinds of solution, put respectively on same silica GF254 lamellae, take toluene-methyl alcohol-glacial acetic acid (80:5:0.1) as solvent, launch, take out, dry, put under ultraviolet lamp (254nm) and inspect.Result with control medicinal material chromatogram relevant position on, the test sample chromatogram is the spot of aobvious same color all, the negative control product are without corresponding spot.
(6) the balloonflower root thin layer is differentiated and is got this product powder 10 g, adds 7% sulfuric acid alcohol-water (1:3) and mixes molten 30 mL, and 3 h reflux, let cool, extract 2 times each 30 mL with the chloroform jolting, merge chloroform liquid, add water washing 2 times, each 30 mL, discard washing lotion, chloroform liquid anhydrous sodium sulfate dehydration filters the filtrate evaporate to dryness, residue adds methyl alcohol 1 mL makes dissolving, as need testing solution.Get balloonflower root control medicinal material 5 g, be made in the same way of control medicinal material solution.Get preparation 5 g that lack balloonflower root, be made in the same way of negative control solution.According to the thin-layered chromatography test, draw above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take chloroform-ether (2:1) as solvent, launch, take out, to dry, spray is heated to the spot colour developing at 105 ℃ clear with 10% ethanol solution of sulfuric acid.Result with control medicinal material chromatogram relevant position on, the spot of the aobvious same color of test sample chromatogram, the negative control product are without corresponding spot.
(7) thin layer of the root of Dahurain angelica is differentiated and is got this product powder 10 g, and 20 mL that add diethyl ether soak 2 h, and jolting constantly filters, and filtrate volatilizes, and residue adds ethyl acetate 1 mL makes dissolving, as need testing solution.Get root of Dahurain angelica control medicinal material 0.5 g, be made in the same way of control medicinal material solution.Get preparation 5 g that lack the root of Dahurain angelica, be made in the same way of negative control solution.Get Imperatorin, Isomperatorin reference substance, add ethyl acetate and make the solution that every 1 mL contains 1mg, product solution in contrast.According to thin-layered chromatography (10 editions appendix VI B of Chinese Pharmacopoeia) test, draw above-mentioned five kinds of solution, put respectively on same silica gel g thin-layer plate, take benzinum (30-60 ℃)-ether (3:2) as solvent, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect.Result with reference substance chromatogram and control medicinal material chromatogram relevant position on, the spot of the aobvious same color of test sample chromatogram, the negative control product are without corresponding spot.
(8) thin layer of rattletop is differentiated and is got this product powder 10g, adds ethanol 150ml, adds hot reflux 1 hour, filters, and filtrate evaporate to dryness, residue add ethanol 1ml makes dissolving, as need testing solution.Separately get forulic acid reference substance, isoferulic acid reference substance, add ethanol and make the solution that every 1ml contains 1mg, in contrast product solution.According to thin-layered chromatography (appendix VI B) test, draw each 10 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take benzene-chloroform-glacial acetic acid (6:1:0.5) as solvent, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect.In the test sample chromatogram, with reference substance chromatogram corresponding position on, the fluorescence spot of aobvious same color.
The assay of general flavone in experimental example 2 granule of the present invention
Adopt ultraviolet spectrophotometry, measure general flavone content in preparation.
The preparation of 1 solution
1.1 sample solution
Get granule, cross 60 mesh sieves after pulverizing, precision takes powder 2 g, adds ultrasonic 30 min of ethanol, is settled to 25 mL, and after shaking up, miillpore filter filters to get sample solution.
1.2 need testing solution
Precision measures sample solution 4 mL and is placed in evaporating dish, add 1 g Silon absorption, fling to ethanol in water-bath or insulating box, then change chromatographic column over to, first wash with 30 mL benzinums, benzinum liquid discards, use the methanol-eluted fractions flavones, collect methanol solution, evaporated under reduced pressure, be settled to 25 mL with the methyl alcohol dissolving again, and get final product.
1.3 reference substance solution
Precision takes control substance of Rutin 5 mg, and with the methyl alcohol dissolving, ultrasonic letting cool with methanol constant volume to 100 mL, namely gets 50 μ g ﹒ mL
-1Reference substance solution.
2 linear relationships are investigated
Get respectively reference substance solution 0,1,2,3,4,5 mL add methyl alcohol to scale in 10 mL volumetric flasks, shake up, and measure absorbance in 360 nm places.Carry out linear regression with reference substance solution concentration (X) and absorbance (Y), getting regression equation is Y=0.0263X-0.0485, r=0.9992(n=6).Result shows, at 0-25 μ g ﹒ mL
-1Scope internal reference product concentration and absorbance are good linear relationship.
3 precision are investigated
Precision measures reference substance solution, and replication 5 times the results are shown in Table 1, shows that instrument precision is good.
Table 1 precision is investigated result
4 study on the stability
The accurate need testing solution of drawing, respectively at 0,2,4,8,12,24 h measure absorbance, the results are shown in Table 2.Result shows, need testing solution is stable in 24 h.
Table 2 study on the stability result
5 repeatability are investigated
Precision takes same batch sample, presses 5 parts of test samples of preparation under the need testing solution item, measures absorbance.The results are shown in Table 3.Result shows, this law repeatability is good.
Table 3 repeatability is investigated result
6 average recoveries are investigated
Precision measures totally 6 parts of the sample solutions of known content, and precision adds reference substance appropriate respectively, and by preparing under the need testing solution item, calculate recovery rate the results are shown in Table 4.This law average recovery rate is 95.14 % as a result, and RSD=1.42 % shows that this law degree of accuracy is better, and method is feasible.
Table 4 average recovery is investigated result
7 sample sizes are measured
By the said determination method, 3 batch samples are measured, calculated content, the results are shown in Table 5.
Table 5 sample size measurement result
The assay of Puerarin in experimental example 3 granule of the present invention
Adopt high performance liquid chromatography, measure the content of Puerarin in preparation.
1 chromatographic condition chromatographic column is ODS-2 HYPERSIL(250 mm * 4.6 mm, 5 μ m), mobile phase is methanol-water (90: 10), flow velocity 1 mLmin
-1Detect wavelength 250 nm, 30 ℃ of column temperatures.
The preparation of 2 solution
Reference substance solution: it is appropriate that precision takes the Puerarin reference substance, and being mixed with concentration with 30% ethanol is 80 μ gmL
-1Solution, and get final product.
Need testing solution: get approximately 0.5 g of this product powder (cross No. three sieve), accurately weighed, precision adds 30% ethanol 50 ml, and weighed weight adds hot reflux 30 min, lets cool, and weighed weight is supplied the weight of less loss with 30% ethanol, shake up, and filtration is got subsequent filtrate, and be get final product.
Negative control solution: get approximately 0.5 g of this product powder of not containing the root of kudzu vine (crossing sieve No. three), with test sample preparation method preparation, and get final product.
3 system suitabilities are got respectively each 10 μ L of reference substance solution, need testing solution and negative sample solution, and injecting chromatograph is measured, and theoretical cam curve is calculated by puerarin peak and is not less than 4000 as a result.Under this chromatographic condition, composition to be measured can be separated preferably, and test sample is having identical chromatographic peak with reference substance chromatographic retention corresponding position, and negative control is noiseless.
The investigation precision of 4 linear relationships measures reference substance solution 1,2,3,4,5 mL put respectively in 5 ml volumetric flasks, add 30% ethanol constant volume, each sample introduction 10 μ L, measure peak area, with peak area (Y), sample size (X) is returned, getting regression equation is Y=184098X+10
6, r=0.9992 shows, in 16 ~ 80 μ g scopes, Puerarin sample size and peak area are good linear relationship.
5 precision are investigated precision and are measured above-mentioned reference substance solution, and each sample introduction 10 μ L repeat sample introduction 5 times, and recording RSD is 0.39 %, shows, instrument precision is good.
Table 6 precision is investigated result
6 study on the stability precisions measure same need testing solution, respectively at 0,2, and 4,8,12,24 h, sample introduction 10 μ L measure, and RSD is 2.10%, shows, and need testing solution is stable in 24 h.
Table 7 study on the stability result
7 reappearances are investigated precision and are taken 5 parts of same batch samples, and by preparing under the need testing solution item, sample introduction 10 μ L measure, and calculating RSD is 1.77 %, shows, this law reappearance is good.
Table 8 reappearance is investigated result
8 average recoveries are investigated totally 6 parts of the accurate sample solutions that measures known content, precision adds reference substance appropriate respectively, by preparing under the need testing solution item, sample introduction 10 μ L measure, calculate recovery rate, the results are shown in Table 9, show that this law average recovery rate is 106.70%, RSD=1.68%, show that this law degree of accuracy is better, method is feasible.
Table 9 average recovery is investigated result
The assay of 9 samples carries out assay by the said determination method to 3 batch samples, calculates with external standard method, the results are shown in Table 10, shows, in granule, puerarin content is 1.5 mg ﹒ g
-1
According to the assay result of 3 batch samples, the tentative every 1g of this product contains Puerarin and must not be less than 1.2mg (1.5 mg * 80%).
Puerarin content measurement result in table 10 3 batch samples
Functional evaluation, the toxicologic study of experimental example 4 preparations
1 has the auxiliary hyperglycemic function evaluation experimental
1.1 the sample sample is the granule of this product, this experiment adopts 5,10,20 times of taking doses as tested material.
1.2 animal used as test is selected adults, (26 ± 2g) single sexes, every group of 10-15 only to select mouse.
1.3 dosage grouping and given the test agent give the time experiment and establish three dosage groups, a model control group.Take 10 times of human body recommended amounts as one of them dosage group, separately establish two dosage groups.Establish simultaneously the intact animal group that gives the given the test agent high dose.It is 30 days that given the test agent gives the time.
1.4 the fasting of hyperglycemia model animal gave the Streptozotocin modeling after 24 hours, and after 5-7 days fasting 3-5 hour, survey blood sugar, blood glucose value 10-25mmol/L is hyperglycemia model success animal.
Select the hyperglycemia model animal to divide into groups by the blood sugar level of fasting 3-5 hour 1.4.1 reduce the fasting blood-glucose experiment, select at random 1 model control group and 3 dosage groups (the poor 1.1mmol/L that is not more than between group).The dosage group gives the variable concentrations given the test agent, and model control group gives solvent, continuous 30 days, surveys fasting blood sugar (fasting is front with experiment), relatively each treated animal blood glucose value and blood sugar decline percentage.Blood glucose value * 100% before blood sugar decline percentage=(blood glucose value after blood glucose value before experiment-experiment)/experiment.Select the healthy adult animal to divide into groups by the blood sugar level of fasting 3-5 hour, select at random 1 control group and 1 given the test agent group (high dose), remaining operation is the same.
1.4.2 sugar tolerance experiment hyperglycemia model animal fasting 3-5 hour, the dosage group gives the variable concentrations given the test agent, model control group gives with the volume solvent, gave glucose 2.0g/kg by mouth in 15-20 minute, mensuration to glucose after 0,0.5,2 hour blood glucose value or give medical starch after the blood glucose value of 0,1,2 hour, observe model control group and given the test agent group to glucose after the variation of each time point Area under the curve of blood glucose.
Area under the curve of blood glucose :=1/2 * (0 hours blood glucose value+0.5 hours blood glucose value) * 0.5+1/2 * (2 hours blood glucose values+0.5 hours blood glucose value) * 1.5=0.25 * (0 hours blood glucose value+4 * 0.5 hours blood glucose values+3 * 2 hours blood glucose values)
1.6 data are processed and result is judged
Data can be used variance analysis, but need first to carry out homogeneity test of variance by the program of variance analysis, and variance is neat, calculates the F value, F value＜F
0.05, conclusion: each organizes no significant difference between mean; The F value〉F
0.05, P＜0.05 is added up with the comparative approach in twos that all belongs between a plurality of experimental group and control group.
Fall the fasting blood-glucose experiment: under the prerequisite that model is set up, given the test agent dosage group and control group compare, and the fasting blood-glucose measured value reduces or blood sugar decline percentage has statistical significance, can judge that the fasting blood-glucose experimental result positive falls in this given the test agent.
Sugar tolerance experiment: under the prerequisite that model is set up, given the test agent dosage group and control group are relatively, 0,0.5,2 hours blood glucose TG-AUCs reduce after giving glucose or medical starch statistical significance, can judge that this given the test agent sugar tolerance experimental result is positive.
1.7 result
Per os gives the granule of the present invention 30 days of mouse various dose, and middle and high dosage experiments group mouse blood sugar decline percentage and model control group relatively have significant difference (P＜0.05), and present dose-effect relationship; Each experimental mice Area under the curve of blood glucose and model control group be there was no significant difference (P＞0.05) relatively; On the intact animal group fasting blood-glucose that gives the given the test agent high dose without impact.Experimental result can be judged, the granule auxiliary hyperglycemic function results of animal positive of the present invention.
2 toxicologic studies
Measurement result shows, mouse takes granule per os acute toxicity testing LD of the present invention
50Greater than 15.0 g/kg.bw, belong to nontoxic level according to toxicity grading.Micronuclei in mice, mouse sperm deformity are tested, Salmonella reversion test is all negative.30d feeds experiment the indices such as routine blood test, blood biochemistry index, organ coefficient and body weight, weightening finish, food-intake, food utilization is showed no harmful effect.Histopathology is observed, and liver,spleen,kidney, Stomach duodenum, testis, ovary are showed no significant pathological change.
Experimental example 5 human experiment experiments
Select selection state of an illness after diet control or OHA treatment more stable, do not need to change types of drugs and dosage, only take the adult Patients with NIDDM of maintenance dose, Kong abdomen Xue Tang＞=7.8 mmol/L (140 mg/dl) or 2h Xue Tang＞=11.1 mmol/L (200 mg/dl) after the meal; After also can selecting 7.8 mmol/L＞=empty abdomen blood sugar＞=6.7 mmol/L (120 mg/dl) or 11.1 mmol/L＞=meal＞=hyperglycemia population of 2 h blood sugar＞=7.8 mmol/L.Viewing duration, the experimenter stops using and treats diabetes medicament and other relevant health foods, and the time is 2 months.The result of test-meal shows, after patients with NIDDM was taken health food of the present invention, the main clinic symptoms such as thirsty many drinks, polyorexia, lassitude hypodynamia, diuresis all were improved.
Above-mentioned functions evaluation experimental and human experiment are tested and are shown, health food of the present invention has auxiliary hyperglycemic function, and has no side effect.
Protection scope of the present invention can not be thought and is confined to the above-mentioned specific embodiment and instantiation.Concerning the person of an ordinary skill in the technical field, under the basic premise that does not break away from the present invention's design, can also make some simple deductions or be equal to replacement, these are equal to alternative and still will be regarded as within protection scope of the present invention.
Claims (6)
1. one kind towards medical insurance health food composition, and it is characterized in that: it is the preparation of being made by the raw material of following weight proportioning:
Root of kudzu vine 4-60 part, dandelion 2-30 part, Chinese yam 2-30 part, fruit of Chinese magnoliavine 1-15 part, tuber of dwarf lilyturf 1-15 part, balloonflower root 1-15 part, root of Dahurain angelica 1-15 part, rattletop 1-15 part.
2. according to claim 1 towards medical insurance health food composition, it is characterized in that: it is the preparation of being made by the raw material of following preferred weight proportioning:
20 parts of the roots of kudzu vine, 10 parts of dandelions, 10 parts of Chinese yams, 5 parts, the fruit of Chinese magnoliavine, 5 parts of the tuber of dwarf lilyturfs, 5 parts of balloonflower roots, 5 parts of the roots of Dahurain angelica, 5 parts of rattletops.
3. according to claim 1-2 any one are described towards medical insurance health food composition, it is characterized in that: it is to be active component by the root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop medicinal material or medicinal substances extract, adds the preparation that the acceptable auxiliary material of health food or complementary composition are prepared from.
4. according to claim 3 towards medical insurance health food composition, it is characterized in that: described preparation formulation comprises: pill, powder, granule, tablet, chewable tablets, capsule, soft capsule, oral liquid, paste, concentrate, paste, custard, cake, beverage.
5. prepare the method towards medical insurance health food composition claimed in claim 1, it is characterized in that: it comprises the steps:
(1) take the raw material of weight proportion: root of kudzu vine 4-60 part, dandelion 2-30 part, Chinese yam 2-30 part, fruit of Chinese magnoliavine 1-15 part, tuber of dwarf lilyturf 1-15 part, balloonflower root 1-15 part, root of Dahurain angelica 1-15 part, rattletop 1-15 part;
(2) get that the root of kudzu vine, dandelion, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop add water or organic solvent extracts, get extract 1, get Chinese yam, be ground into fine powder, cross 100 mesh sieves, yam flour, or get that the root of kudzu vine, dandelion, Chinese yam, the fruit of Chinese magnoliavine, the tuber of dwarf lilyturf, balloonflower root, the root of Dahurain angelica, rattletop add water or organic solvent extracts, get extract 2;
(3) get extract 1 and yam flour mixing, add acceptable auxiliary material or complementary composition in health food, make respectively preparation by corresponding shaping technique, or get extract 2 and add acceptable auxiliary material or complementary composition in health food, make respectively preparation by corresponding shaping technique.
6. the described composition of claim 1-5 any one has purposes in the health food of auxiliary hyperglycemic function in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100465080A CN103110100A (en) | 2013-02-05 | 2013-02-05 | Korean medical healthcare food composition as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100465080A CN103110100A (en) | 2013-02-05 | 2013-02-05 | Korean medical healthcare food composition as well as preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103110100A true CN103110100A (en) | 2013-05-22 |
Family
ID=48408493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100465080A Pending CN103110100A (en) | 2013-02-05 | 2013-02-05 | Korean medical healthcare food composition as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110100A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106072626A (en) * | 2016-06-06 | 2016-11-09 | 延吉朝耀生物科技有限公司 | A kind of towards doctor's compound recipe antler health-care food and its production and use |
| CN107041924A (en) * | 2017-03-17 | 2017-08-15 | 延吉朝耀生物科技有限公司 | It is a kind of prevent and treat diabetic nephropathy towards medicine compound extract and preparation method thereof |
| CN108553584A (en) * | 2018-06-19 | 2018-09-21 | 延边大学 | A kind of composition of auxiliary hyperglycemic and its application |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810625A (en) * | 2010-04-09 | 2010-08-25 | 上海新康制药厂 | Application of dandelion sterols |
| CN102860505A (en) * | 2011-11-21 | 2013-01-09 | 延边大学 | Korean medicinal healthcare food composition with effect of assisting in protecting gastric mucosa, and preparation method and use thereof |
-
2013
- 2013-02-05 CN CN2013100465080A patent/CN103110100A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810625A (en) * | 2010-04-09 | 2010-08-25 | 上海新康制药厂 | Application of dandelion sterols |
| CN102860505A (en) * | 2011-11-21 | 2013-01-09 | 延边大学 | Korean medicinal healthcare food composition with effect of assisting in protecting gastric mucosa, and preparation method and use thereof |
Non-Patent Citations (3)
| Title |
|---|
| 于学康: "麦冬的药理作用研究进展", 《天津药学》, vol. 24, no. 4, 31 December 2012 (2012-12-31), pages 69 - 70 * |
| 张文达等: "糖尿灵1号治疗2型糖尿病临床体会", 《中国社区医师（医学专业半月刊）》, no. 12, 31 December 2008 (2008-12-31), pages 72 * |
| 陈雪花等: "浅述朝医对消渴病的治疗", 《中国民族医药杂志》, no. 7, 31 July 2008 (2008-07-31), pages 29 - 30 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106072626A (en) * | 2016-06-06 | 2016-11-09 | 延吉朝耀生物科技有限公司 | A kind of towards doctor's compound recipe antler health-care food and its production and use |
| CN106072626B (en) * | 2016-06-06 | 2018-10-09 | 延吉朝耀生物科技有限公司 | It is a kind of towards doctor's compound antler health-care food and its preparation method and application |
| CN107041924A (en) * | 2017-03-17 | 2017-08-15 | 延吉朝耀生物科技有限公司 | It is a kind of prevent and treat diabetic nephropathy towards medicine compound extract and preparation method thereof |
| CN108553584A (en) * | 2018-06-19 | 2018-09-21 | 延边大学 | A kind of composition of auxiliary hyperglycemic and its application |
| CN108553584B (en) * | 2018-06-19 | 2021-01-01 | 延边大学 | A kind of composition for assisting hypoglycemic and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105998297A (en) | Traditional Chinese medicine composition with effects of moistening intestines and relaxing bowels and preparation method thereof | |
| CN1299742C (en) | Medicine for treating diabetes, and its prepn. method | |
| CN104491342A (en) | Medicament for treating diabetes and preparation method thereof | |
| CN103110100A (en) | Korean medical healthcare food composition as well as preparation method and application thereof | |
| CN102652819B (en) | Fuyankang dispersible tablet and preparation method thereof | |
| CN104491797A (en) | Use of traditional Chinese medicine preparation in preparation of drug for treating intestinal parasites | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN103989996B (en) | It is a kind of to treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN104922548A (en) | Chinese herbal preparation for treatment of ascariasis | |
| CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
| CN104958615B (en) | A kind of Chinese medicine composition of prevention and treatment II diabetes and preparation method thereof | |
| CN105533749B (en) | It is a kind of containing Herba Epimedii, the health food of Schisandra chinensis and its preparation method and application | |
| CN103432420A (en) | Traditional Chinese medicine composition for treating diabetes, and preparation method and detection method thereof | |
| CN107007702A (en) | A kind of Chinese medicine composition and its preparation for treating osteoarthropathy | |
| CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
| CN104491318A (en) | Traditional Chinese preparation used for treating asthma and preparation method of traditional Chinese preparation | |
| CN1272047C (en) | Medicine for invigorating liver and kidney to treat dryness of large intestine and constipation | |
| CN117731749B (en) | A Chinese medicine composition for treating cancer pain and its preparation method and application | |
| CN104352797A (en) | Traditional Chinese medicine for treating advanced lung cancer and application of traditional Chinese medicine | |
| CN104055845A (en) | Composition for treating diseases of heart and cerebral vessel, liver and kidney and boosting immunity and preparation thereof | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN103263581A (en) | Shuangshen capsule for reducing blood sugar | |
| CN100486621C (en) | Chinese medicinal composition for treating hemilateral headache and its preparation method | |
| CN1064536C (en) | Full-divergence promoting medicine for curing fourth-phase carcinoma of stomach and its processing method | |
| CN120021767A (en) | Preparation method and application of Korean medicine health food for assisting in lowering blood sugar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130522 |